戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sion associated with the haplotype of the F7 founder line.
2 lines derived from eight genetically diverse founder lines.
3 although this was more variable in different founder lines.
4 orter gene and used to create six transgenic founder lines.
5  variable levels of expression in individual founder lines.
6 cDNA and utilized this transgene to generate founder lines.
7 tissues, including the thymus in some of the founder lines.
8 GIC) population for lettuce using 16 diverse founder lines.
9 ric bud causes reduced branching in multiple founder lines.
10 lies; however, allelic effects differ across founder lines.
11            Whole-genome sequencing of the 16 founder lines and 381 inbred progeny reveal minimal popu
12 tween 3- and 50-fold higher depending on the founder line, and this occurred within 24-48 h after dos
13 rsensitive sites, is expressed in only a few founder lines, and expression is dysregulated in CD8(+)
14 sed across the 26 nested association mapping founder lines, and this variability positively correlate
15 derived from two independent TetOp-DeltaFosB founder lines but not in single NSE-tTA transgenic contr
16                               Study of three founder lines by FACS showed overexpression to varying e
17                                          The founder line carrying eight copies of this transgene has
18                                 We created 2 founder lines carrying a floxed eNOS (eNOS(flox/flox)) f
19      The analysis of mice from six different founder lines demonstrated that this genomic DNA fragmen
20        WAP-h-Int3sh females from each of the founder lines develop mammary tumors, but with a long la
21       Although some transgenic mice from one founder line developed amyloidosis in the intestine, no
22                                          One founder line developed compound MTC/PTC at low frequency
23                              Some transgenic founder lines did not demonstrate reporter gene expressi
24                                   Two of the founder lines did not have a demonstrable phenotype (M-4
25 ary thyroid carcinoma (PTC) depending on the founder line examined.
26                        Two of six transgenic founder lines exhibited brain-selective expression of th
27                                   All tested founder lines exhibited red blood cell-specific expressi
28                                    All three founder lines exhibited strong suppression of IgE in res
29                                          The founder line exhibiting the highest level of suppression
30                  Twelve of twlve NPHS2 mouse founder lines expressed beta-gal exclusively in podocyte
31                                        Three founder lines expressed this transgene and constitutivel
32 2 generations of free recombination among 60 founder lines, following modification of the mating syst
33  DNA integrations in our genomic engineering founder lines for the purpose of generating complex knoc
34 ere human CD8 beta+ varied, depending on the founder line, from 4 to 88%, whereas the percentage amon
35                               In each of six founder lines, high-level luciferase activity was eviden
36 ckcrossed homozygous transgenic animals from founder line I had plasma PAI-1 levels of 23+/-12 ng/mL.
37 erminal repeat (MMTV-LTR) promoter, and four founder lines identified.
38            (5) Including observations on the founder lines in the QTL analysis should be avoided as i
39 in thymic lymphomas from multiple transgenic founder lines, including one line in which 15 of 15 prim
40  is produced in nonlymphoid tissues from all founder lines, including tissues that do not express end
41             Mammary gland development in all founder lines is normal and the females can lactate.
42            Formation of epiblast (EPI) - the founder line of all embryonic lineages - and extra-embry
43 6 -> Ser) was used to generate 15 transgenic founder lines of hA-IImon mice, that contained plasma hA
44 tively transferred into different transgenic founder lines of mice expressing HA as a peripheral self
45                        We generated multiple founder lines of mice with cardiac-restricted overexpres
46 ge number of contrasting RSA traits among 25 founder lines of the maize nested association mapping po
47 and B cells from three independently derived founder lines of transgenic mice bearing a recombined he
48 hematopoietic disease, we developed separate founder lines of transgenic mice, with the tetracycline
49                                              Founder line TgA, with the lowest level of IL-7 overexpr
50   In contrast, in the highest overexpressing founder line, TgB, alphabeta T-cell development was dist
51                             A transactivator founder line that strongly expressed PF4-driven tTA-vira
52 We generated two independent transgenic mice founder lines that express a stable variant of active hu
53                           In two independent founder lines, this -306 to +3 promoter region was suffi
54                                 Breeding two founder lines together produced mice with an activity of
55 itively correlate with SPS in multiple MAGIC founder lines under field conditions as well as in trans
56 evealed that one 570 kb YAC, in two separate founder lines, was associated with distinct learning def
57                               Two transgenic founder lines were generated and independently bred to s